SOD2 and metabolic dysfunction-associated steatotic liver disease: Additionally, the C47T polymorphism in the gene encoding superoxide dismutase 2 (SOD2) has been associated with reduced SOD2 activity, elevated ROS levels, and an increased risk of NASH development and advanced fibrosis in NAFLD.